Fidelity Investments’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Fidelity Investments’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$794K	Buy	2,915 +445	+18%	+$116K	﹤0.01%	3122
2026 Q2	$612K	Buy	2,470 +179	+8%	+$38.6K	﹤0.01%	3207
2026 Q1	$460K	Buy	2,291 +1,159	+102%	+$240K	﹤0.01%	3161
2025 Q4	$234K	Sell	1,132 -11	-1%	-$2.2K	﹤0.01%	3365
2025 Q3	$205K	Buy	1,143 +160	+16%	+$27.2K	﹤0.01%	3333
2025 Q2	$159K	Sell	983 -223	-18%	-$35.5K	﹤0.01%	3408
2025 Q1	$205K	Buy	1,206 +136	+13%	+$23.6K	﹤0.01%	3235
2024 Q4	$178K	Buy	1,070 +77	+8%	+$13.2K	﹤0.01%	3316
2024 Q3	$171K	Sell	993 -35	-3%	-$5.79K	﹤0.01%	3252
2024 Q2	$158K	Buy	1,028 +38	+4%	+$5.7K	﹤0.01%	3116
2024 Q1	$152K	Sell	990 -456	-32%	-$69.5K	﹤0.01%	3122
2023 Q4	$229K	Buy	1,446 +826	+133%	+$119K	﹤0.01%	2927
2023 Q3	$90.7K	Buy	620 +2	+0.3%	+$305	﹤0.01%	3130
2023 Q2	$94.6K	Sell	618 -4	-0.6%	-$624	﹤0.01%	3184
2023 Q1	$96.4K	Sell	622 -42	-6%	-$6.6K	﹤0.01%	3219
2022 Q4	$102K	Sell	664 -282	-30%	-$41.6K	﹤0.01%	3202
2022 Q3	$125K	Sell	946 -191	-17%	-$26.8K	﹤0.01%	3198
2022 Q2	$154K	Buy	1,137 +301	+36%	+$41.5K	﹤0.01%	3200
2022 Q1	$125K	Sell	836 -84	-9%	-$12.4K	﹤0.01%	3385
2021 Q4	$149K	Sell	920 -13	-1%	-$2.1K	﹤0.01%	3007
2021 Q3	$155K	Sell	933 -37	-4%	-$6.32K	﹤0.01%	2994
2021 Q2	$167K	Buy	970 +648	+201%	+$107K	﹤0.01%	2952
2021 Q1	$52K	Buy	322 +95	+42%	+$16.3K	﹤0.01%	3037
2020 Q4	$38K	Buy	227 +39	+21%	+$6.33K	﹤0.01%	3049
2020 Q3	$30K	Sell	188 -66	-26%	-$10.8K	﹤0.01%	2972
2020 Q2	$43K	Sell	254 -39	-13%	-$6.12K	﹤0.01%	2832
2020 Q1	$38K	Buy	293 +18	+7%	+$2.56K	﹤0.01%	2823
2019 Q4	$41K	Buy	275 +85	+45%	+$11.7K	﹤0.01%	2938
2019 Q3	$24K	Sell	190 -6	-3%	-$799	﹤0.01%	3023
2019 Q2	$28K	Buy	196 +26	+15%	+$3.59K	﹤0.01%	2997
2019 Q1	$25K	Buy	170 +169	+16,900%	+$24.3K	﹤0.01%	2922
2018 Q4	$0	Buy	+1	New	+$137	﹤0.01%	3678

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

Berger Financial Group Plymouth, Minnesota $2.01B AUM 15.82% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.42B AUM 19.31% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

Fidelity Investments's FBT Position: Q3 2026 in Review

Fidelity Investments increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 18% in Q3 2026, buying an estimated $116K and bringing the position to 2,915 shares worth $794K. The position accounts for ﹤0.01% of the portfolio, ranked #3122.

Fidelity Investments first reported a position in FBT in Q4 2018 and has held it in 32 quarters since. 295 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

Fidelity Investments held 2,915 shares of First Trust NYSE Arca Biotechnology Index Fund worth $794K as of Q3 2026.
Fidelity Investments bought 445 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $116K.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #3122 holding.
Fidelity Investments first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2018 and has held it in 32 quarters since.
295 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.